Product Code: ETC13349119 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Radiopharmaceutical Theranostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Radiopharmaceutical Theranostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Radiopharmaceutical Theranostics Market - Industry Life Cycle |
3.4 Global Radiopharmaceutical Theranostics Market - Porter's Five Forces |
3.5 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.10 Global Radiopharmaceutical Theranostics Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Global Radiopharmaceutical Theranostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Radiopharmaceutical Theranostics Market Trends |
6 Global Radiopharmaceutical Theranostics Market, 2021 - 2031 |
6.1 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Beta Emitters, 2021 - 2031 |
6.1.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Alpha Emitters, 2021 - 2031 |
6.1.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Positron Emitters, 2021 - 2031 |
6.1.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.2.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Radiotracers, 2021 - 2031 |
6.4.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Imaging Agents, 2021 - 2031 |
6.4.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Agents, 2021 - 2031 |
6.4.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.5.3 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.5.4 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.5.5 Global Radiopharmaceutical Theranostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Radiopharmaceutical Theranostics Market, Overview & Analysis |
7.1 North America Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
7.7 North America Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
8 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
8.7 Latin America (LATAM) Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
9 Asia Radiopharmaceutical Theranostics Market, Overview & Analysis |
9.1 Asia Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
9.7 Asia Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
10 Africa Radiopharmaceutical Theranostics Market, Overview & Analysis |
10.1 Africa Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
10.7 Africa Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
11 Europe Radiopharmaceutical Theranostics Market, Overview & Analysis |
11.1 Europe Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
11.7 Europe Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
12 Middle East Radiopharmaceutical Theranostics Market, Overview & Analysis |
12.1 Middle East Radiopharmaceutical Theranostics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Radiopharmaceutical Theranostics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By Component, 2021 - 2031 |
12.7 Middle East Radiopharmaceutical Theranostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
13 Global Radiopharmaceutical Theranostics Market Key Performance Indicators |
14 Global Radiopharmaceutical Theranostics Market - Export/Import By Countries Assessment |
15 Global Radiopharmaceutical Theranostics Market - Opportunity Assessment |
15.1 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By Component, 2021 & 2031F |
15.6 Global Radiopharmaceutical Theranostics Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
16 Global Radiopharmaceutical Theranostics Market - Competitive Landscape |
16.1 Global Radiopharmaceutical Theranostics Market Revenue Share, By Companies, 2024 |
16.2 Global Radiopharmaceutical Theranostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |